Vol. 153, No. 2 JOURNAL OF CONTROLLED RELEASE 30 JULY 2011

CONTENTS

Cited in: BIOSIS/Biological Abstracts; CAB Abstracts; Chemical Abstracts Services; Current Contents (Life Sciences); EMBASE/Excerpta Medica; International Pharmaceutical Abstracts; PUBMED/MEDLINE/Index Medicus; Polymer Contents; Science Citation Index. Also covered in the abstract and citation database SCOPUS®. Full text available in ScienceDirect®

www.sciencedirect.com

Available online at

Cover StoryUnraveling the penetration: Model giant plasma membrane vesicles for study of cell-penetrating peptides

K. Park (West Lafayette, IN, USA) 105

ReviewAdvances in oral transmucosal drug delivery

V.F. Patel, F. Liu and M.B. Brown (Hatfield, Surrey, UK) 106

Research PapersPenetration without cells: Membrane translocation of cell-penetrating peptides in the model giant plasma membrane vesicles

P. Säälik, A. Niinep, J. Pae, M. Hansen, D. Lubenets, Ü. Langel and M. Pooga (Tartu, Estonia; Stockholm, Sweden) 117Novel micelle formulations to increase cutaneous bioavailability of azole antifungals

Y.G. Bachhav, K. Mondon, Y.N. Kalia, R. Gurny and M. Möller (Geneva, Switzerland) 126Porous hydroxyapatite scaffold with three-dimensional localized drug delivery system using biodegradable microspheres

J.S. Son, M. Appleford, J.L. Ong, J.C. Wenke, J.M. Kim, S.H. Choi and D.S. Oh (San Antonio, Fort Sam Houstion, TX, USA;Republic of Korea) 133

Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene deliveryG. Kibria, H. Hatakeyama, N. Ohga, K. Hida and H. Harashima (Sapporo, Japan) 141

Gene DeliveryAn effective gene-knockdown using multiple shRNA-expressing adenovirus vectors

Y. Motegi, K. Katayama, F. Sakurai, T. Kato, T. Yamaguchi, H. Matsui, M. Takahashi, K. Kawabata and H. Mizuguchi(Osaka, Nagoya, Japan) 149

Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protectiveimmunity against Leishmania major infectionD. Doroud, F. Zahedifard, A. Vatanara, A.R. Najafabadi, Y. Taslimi, R. Vahabpour, F. Torkashvand, B. Vaziri and S. Rafati(Tehran, Iran) 154

Insights into the cellular trafficking of splice redirecting oligonucleotides complexed with chemically modified cell-penetratingpeptidesF. Said Hassane, R. Abes, S. EL Andaloussi, T. Lehto, R. Sillard, Ü. Langel and B. Lebleu (Montpellier cedex, France; Tartu, Estonia;Stockholm, Sweden) 163

NanomedicineConformational consequences of cooperative binding of a coiled-coil peptide motif to poly(N-(2-hydroxypropyl) methacrylamide)

HPMA copolymersP.C. Griffiths, A. Paul, B. Apostolovic, H.-A. Klok, E. de Luca, S.M. King and R.K. Heenan (Wales, Oxfordshire, United Kingdom;Lausanne, Switzerland) 173

Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oraladministrationT.-H. Nguyen, T. Hanley, C.J.H. Porter and B.J. Boyd (Parkville, VIC, Menai, NSW, Australia) 180

Hyperthermia-triggered intracellular delivery of anticancer agent to HER2+ cells by HER2-specific affibody (ZHER2-GS-Cys)-conjugated thermosensitive liposomes (HER2+ affisomes)B. Smith, I. Lyakhov, K. Loomis, D. Needle, U. Baxa, A. Yavlovich, J. Capala, R. Blumenthal and A. Puri (Frederick, Bethesda,MD, USA) 187

Calendar 195JO

UR

NA

L OF

CO

NT

RO

LLED

RE

LEA

SE

V

OL. 153 (2011) P. 105

–196

1532

EL

SEV

IER

05054

OFFICIAL JOURNAL OF THE CONTROLLED RELEASE SOCIETYAND THE JAPANESE SOCIETY OF DRUG DELIVERY SYSTEM

VOLUME 153, NO. 2, 30 JULY 2011 ISSN: 0168-3659

COVER STORYUnraveling the penetration: Model giant plasma membrane vesicles for study of cell-penetrating peptides

4